Abbott's MDx Sales Rise 21 Percent in Q2 | GenomeWeb

NEW YORK (GenomeWeb News) – Abbott today reported worldwide molecular diagnostics sales of $73 million, up around 21 percent, not including the effects of currency translation, over its 2008 MDx sales.

The Abbott Park, Ill.-based pharmaceuticals and medical products giant said that including the negative effects of foreign exchange its global molecular diagnostic sales were up 11 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.